Prostate Cancer Study Suggests Shorter Hormone Treatment As Good as Longer Treatment

A study of 630 high-risk localized prostate cancer patients shows 18 months of hormonal therapy is likely as good as 36 months of therapy. The results were presented at the ASCO Genitourinary Cancers Symposium press conference. The patients, followed for a median of 6.5 years will be followed up for several more years.

Fueling Prostate Cancer with Stress

In general, stress is not a good thing. Chronic stress can prevent the immune system from working properly and interfere with healing and recovery. Studies have even suggested that chronic stress may stimulate carcinogenesis and prevent response to therapy, but this has not been extensively explored.

Now, researchers led by George Kulik, a biologist at the Wake Forest Baptist Medical Center, are among the first to show that behavioral stress can worsen prostate cancer outcomes. Continue reading…